My HPRA: Register

MODECATE CONCENTRATE

100 Mg/Ml Solution for Injection

Bristol-Myers Squibb Pharmaceuticals LtdPA0002/031/001

Main Information

Trade NameMODECATE CONCENTRATE
Active SubstancesFLUPHENAZINE DECANOATE
Strength100 Mg/Ml
Dosage FormSolution for Injection
Licence HolderBristol-Myers Squibb Pharmaceuticals Ltd
Licence NumberPA0002/031/001

Group Information

ATC CodeN05AB02 Antipsychotic

Status

Authorised/WithdrawnAuthorised
Licence Issued25/01/1979
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may not be renewed (A)
Marketing StatusMarketed
Promotion StatusPromotion to Healthcare Professionals only
Conditions of Licence

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print

Summary of Product Characteristics

View More SPC Headings

Latest Changes to Medicine Info & SPC

View all available

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.